Skip to main content
. 2015 Dec 18;11(2):467–475. doi: 10.3892/etm.2015.2953

Figure 2.

Figure 2.

Effects of MSC-CM on monocrotaline-induced pulmonary hypertension. Left panels: Histological examination of lung tissue in (A) control, (B) model and (C) MSC-CM treatment groups (hematoxylin and eosin stain; magnification, ×400). Right panels: Changes of (A) RVSP, (B) MAoP and (C) medial WT in each group. Data are presented as mean ± standard deviation (n=6). *P<0.01, **P<0.05. RVSP, right ventricle systolic pressure; MSC-CM, mesenchymal stem cell-conditioned media; MAoP, mean aortic pressure; WT, wall thickness.